Allogene Therapeutics Inc (ALLO)

Allogene Therapeutics Inc Azioni (ALLO) Dati Finanziari

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	100.00%-	4.64	-	-	-
	6.27%54.79	51.56	46.09	42.40	44.90
Research and Development	36.50%41.93	30.72	32.00	28.63	31.16
Operating Income/Loss	16.78%-54.79	-46.92	-46.09	-42.40	-44.90
Nonoperating Income/Loss	4.27%4.42	4.24	3.49	3.59	3.50
	18.02%-50.37	-42.68	-42.61	-38.81	-41.40
Attributable To Parent	18.02%-50.37	-42.68	-42.61	-38.81	-41.40
Basic Average Shares	5.22%346.09	328.93	240.29	-	222.04
Diluted Average Shares	5.22%346.09	328.93	240.29	-	222.04
Basic Earnings Per Share	15.38%-0.15	-0.13	-0.18	-	-0.19
Diluted Earnings Per Share	15.38%-0.15	-0.13	-0.18	-	-0.19